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Abstract
Background: The median laparotomy is frequently used by abdominal surgeons to gain rapid and wide access to
the abdominal cavity with minimal damage to nerves, vascular structures and muscles of the abdominal wall.
However, incisional hernia remains the most common complication after median laparotomy, with reported
incidences varying between 2-20%. Recent clinical and experimental data showed a continuous suture technique
with many small tissue bites in the aponeurosis only, is possibly more effective in the prevention of incisional
hernia when compared to the common used large bite technique or mass closure.
Methods/Design: The STITCH trial is a double-blinded multicenter randomized controlled trial designed to
compare a standardized large bite technique with a standardized small bites technique. The main objective is to
compare both suture techniques for incidence of incisional hernia after one year. Secondary outcomes will include
postoperative complications, direct costs, indirect costs and quality of life.
A total of 576 patients will be randomized between a standardized small bites or large bites technique. At least 10
departments of general surgery and two departments of oncological gynaecology will participate in this trial. Both
techniques have a standardized amount of stitches per cm wound length and suture length wound length ratio’s are
calculated in each patient. Follow up will be at 1 month for wound infection and 1 year for incisional hernia.
Ultrasound examinations will be performed at both time points to measure the distance between the rectus muscles
(at 3 points) and to objectify presence or absence of incisional hernia. Patients, investigators and radiologists will be
blinded during follow up, although the surgeon can not be blinded during the surgical procedure.
Conclusion: The STITCH trial will provide level 1b evidence to support the preference for either a continuous suture
technique with many small tissue bites in the aponeurosis only or for the commonly used large bites technique.
Trial registration: Clinicaltrials.gov NCT01132209
Background
The median laparotomy is frequently used by abdominal
surgeons to gain rapid and wide access to the abdominal
cavity with minimal damage to nerves, vascular structures
and muscles of the abdominal wall. However, incisional
hernia remains the most common complication after
median laparotomy, with reported incidences varying
between 2-20%[1-5]. Even higher incidences up to 30-35%
have been reported in obese and aortic aneurysm patients
[6-10]. Incisional hernia can cause discomfort, impair
quality of life or result in serious life-threatening condi-
tions, such as incarceration or strangulation of the bowel
[5]. Median laparotomies and incisional hernias have been
subject of investigation for a long period of time already.
Although a lot is known about patient related risk factors
and suture materials, technical risk factors such as suture
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techniques have not been investigated thoroughly
[5,11,12].
For prevention of incisional hernia, many clinical trials
and meta-analyses have demonstrated that a mass closure
technique with a simple running suture is the best option
to close a midline incision. A mass closure technique
with a running suture is also easier and quicker to per-
form than layered techniques with interrupted sutures
[5,12-14]. Furthermore, the use of slowly resorbable
suture material compared with non-resorbable suture
material decreases the incidence of incisional hernia, and
it also lowers the incidence and intensity of postoperative
pain and wound infection [12,15,16].
Suture length to wound length ratio and small bites
Several authors have stated that a suture length to wound
length ratio (SL:WL) of four or more must be achieved,
since a lower ratio is associated with an increased rate of
incisional hernia [7,17-20]. It has often been recom-
mended to place continuous stitches more than 10 mm
from the wound edge in combination with a long stitch
length [19,21-28]. A long stitch is the result of a large
bite with the largest portion of fascia possible, aiming to
increase tensile strength and to decrease the risk of fas-
cial dehiscence. However, long stitches have been asso-
ciated with high rates of both wound infection and
incisional hernia [17,29,30]. A long stitch length may be
associated with higher risks of wound infection due to an
increase in the amount of necrotic tissue within the
wound. In experimental studies, the long stitch length
has been found to compress or cut through soft tissue
included in the stitch [31,32]. The risk of incisional her-
nia may be higher because the stitch tends to slacken,
which allows wound edges to separate.
Small stitches, placed 4-6 mm from the wound edge,
only cut through the aponeurosis and not through the
rectus abdominis muscle. Recent experimental data
show that the small bites technique results in stronger
wounds and faster healing than the routine large bite
technique [33]. Our experiments in a porcine model
showed a 47% increase in breaking strength when small
bites were used compared to the routine technique [32].
A recent randomized of randomised clinical study by
Millbourn et al. reported a decrease of incidence of inci-
sional hernia of 70% 18% to 5.6%, p < 0.001) and a
decrease of 50%, (10.2% to 5.2%, p = 0.020) of wound
infection [34]. These results are very promising with
regard to the prevention of incisional hernia and wound
infection. The benefits of this technique need to be con-
firmed in a multicenter double-blinded randomized con-
trolled trial.
In daily practice, most surgeons in the Netherlands
use the large bite technique with large suture distances.
With large bites, SL:WL ratio depends on the thickness
of the abdominal wall including the muscles, the bite
size, the number of stitches and the traction on the
sutures during suturing. With large bites, an unan-
swered question remains with regard to how the SL:WL
ratio of 4 should be reached. With a low traction force,
fewer stitches are needed, but the slacking effect during
the postoperative period may influence results.
With small stitches, SL:WL ratio is mostly dependent
on the number of stitches. There is no sufficient evi-
dence to prefer one suture closure technique over the
other in order to prevent incisional hernia and fascia
dehiscence.
Objective
The objective of the STITCH trial (Suture Techniques
to reduce the Incidence of The inCisional Hernia) is to
compare the small bites technique decribed by Mill-
bourn et al. with a standardized large bites technique.
The overall objective of the study is reduction of the
incidence of the most frequent complication of abdom-
inal surgery, i.e., incisional hernia. We hypothesize that
the small bites technique will result in a significant
reduction of the incidence of incisional hernia, which
may lead to a reduced morbidity and a better quality of
life for patients and a significant reduction of costs.
Primary endpoint will be incisional hernia occurrence
within one year after surgery, either clinically and/or
ultrasonographically detected. Secondary endpoints
include postoperative complications, in particular surgi-
cal site infection, burst abdomen and wound pain in the
first postoperative month.
Methods/Design
Trial Design
The STITCH trial has been designed as a prospective,
multicenter, double-blind, randomized controlled trial,
in which the large bites technique will be compared
with the small bites technique.
Participants
Patients scheduled for an elective abdominal operation
through a midline incision will be asked for informed
consent at the outpatient clinic or in hospital on the day
preceding the day of surgery. Also, emergency laparo-
tomies can be included in this trial if the patient is able
to sign the informed consent. We intend to investigate
the efficacy of the small bites technique in all risk
groups. This also includes oncological gynaecological
patients in centers with at least 50 median laparotomies
a year.
Inclusion criteria
• Signed informed consent
• Laparotomy through a midline incision
• Age 18 years or older
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Exclusion criteria
• Previous incisional hernia or fascial dehiscence
with secondary healing after a midline incision
• Abdominal surgery through a midline incision
within the last three months
• Pregnancy
Since the STITCH trial is an intervention study, it is not
considered desirable to combine this trial with other inter-
vention studies. In case of non-intervention (registration)
studies, it will be judged on individual basis whether it is
suitable and ethically correct to include a patient in both
the STITCH trial and in another study. Patients will be
included in the STITCH trial in combination with one
other trial (registration trials only), provided that it is pos-
sible to organize the informed consent and the follow up
in a proper way for the individual patient for both trials.
Registration procedure
Included patient are registrated before surgery in an online
data base (designed and managed by HOVON data center,
Rotterdam, the Netherlands,) after signed informed con-
sent via the Internet via TOP (Trial Online Process; see
http://www.stitchtrial.nl). The patient namecode, date of
birth, name of caller, name of responsible physician, sex
and eligible criteria will be registered. Every participating
institution has its own login code.
Randomisation procedure
The randomization process is started only 15 minutes
before closure to prevent consequences due to the trial
during the operation with the online TOP randomisation.
Patients will be randomized between closure with the
large tissue bites technique or with the small tissue bites
technique. Randomisation is stratified by center, and
between surgeon or resident with a minimization proce-
dure, ensuring balance within each stratum and overall
balance. The randomization result will be given immedi-
ately by TOP. A confirmation email without randomiza-
tion result will be send to the investigator.
Patients will be kept unaware of the type of closure until
the endpoint of the trial. Surgeons or residents blinded for
the procedure will perform out patient clinic controls.
Postoperative ultrasonography will be performed by radi-
ologists blinded for type of closure. The randomisation
procedure, blinding and objectification of incisional hernia
by ultrasound will provide the best possible data to sup-
port preference for the large bites technique or the small
bites technique over the other for closure of the abdominal
wall.
Interventions
In this trial the large bites technique will be compared
with the small tissue bites technique as developed in
Sundsvall Hospital, Sweden [18]. In the first group, the
conventional large bites technique will be applied with
bite widths of 1 cm and intersuture spacing of 1 cm with
the use of one PDS plus II loop with a 48 mm needle. In
the second group, the small bites technique will be
applied with bite widths of 0,5 cm and intersuture spa-
cing of 0,5 cm with the use of PDS plus II 2-0 with a 31
mm needle. In the small bites technique, twice as many
stitches will be placed per sutured cm, with a smaller
needle and thinner suture material. In the Swedish hospi-
tal where the small bites techniques has been in use for
many years, this combination proved the easiest and
safest method to perform the small bites technique
[18,34].
In both groups wound length is measured before closing
of the fascia. After measument of the woundlength, the
number of stitches is calculated. In the large bites techni-
que at least one suture per cm wound length must be
placed. In the small bites technique at least two sutures
per cm wound length must be placed. The number of
stitches is counted by the assistant during closure.
In both arms, suturing is initiated at both ends of the
incision towards the middle where an overlap will be cre-
ated of at least 2 cm. The remaining sutures will be mea-
sured and the suture length used for closure of the fascia
and the SL:WL ratio will be calculated by the scrub nurse.
In both arms, suture length to wound length ratios (SL:
WL) of 4:1 are aimed at.
Implementation
In every hospital the OR nurses the surgeons or gynecolo-
gists and residents are instructed before the start of the
trial in the individual institution during presentations and
demonstration movies. During at least the first five inclu-
sions the study coordinator will be present in the OR
before randomization to assist randomization and control
the correct applying of the standardized techniques. For
every included patient a form with the detailed closing
protocol is added to the clinical chart. Only when the sur-
geon is familiar with both the techniques, the nurses with
the counting and measuring of the stitches and suture
material and the study, centers are allowed to run the trial.
Also, for every included patient a form with the detailed
closing protocol is added to the clinical chart. During the
study unplanned audits are performed to control quality.
Outcome parameters
Primary outcome • Primary outcome will be incisional
hernia occurrence within one year after surgery, either
clinically and/or ultrasonographically detected.
Secondary outcome • Postoperative complications
• Pain
• Quality of life
• Cost effectiveness
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We use the definition of the incisional hernia by the
European Hernia Society: ‘any abdominal wall gap with
or without bulge in the area of a postoperative scar per-
ceptible or palpable by clinical examination or imaging’.
The classification made by the European Hernia Society
is used [35]. The classification of incisional hernias: Inci-
sional hernias will be classified according to their locali-
zation, size, reducibility and symptoms.
Discharge dates and complications will be registered.
Patients who fail to keep their annual clinic appointment
will be given the option of a further appointment at a
more suitable date or a visit to their home if they cannot
make it to the outpatient clinic. The following data will
be gathered at different points in time:
Preoperative data • Date of birth
• Length and weight
• Current smoker (Yes or No)
• Medical history (including chronic obstructive pul-
monary disease (COPD), diabetes mellitus, cardiac
disease, prior laparotomies)
• Preoperative radiotherapy or chemotherapy
• Preoperative or perioperative corticosteroids
• Previous abdominal operations
• Other abdominal wall hernias
• American Society of Anaesthesiologists (ASA)
classification
• Width of linea alba (if preoperative Computed
Tomography Imaging is available)
Operation data
• Type of operation
• Suture length: wound length ratio
• Number of stitches
• Length of incision
• Closure time
• Blood loss
• Operation time
• Antibiotic prophylaxis
• Drains and location
• Thrombosis prophylaxis
• Pain medication
• Peroperative complications (intestinal lesions,
bleeding, other)
• Epidural catheter
Postoperative data
• Blood transfusion
• Postoperative ventilation and duration
• Postoperative corticosteroids
• Postoperative radiation therapy
• Postoperative pain medication
• Postoperative ileus and duration
• Postoperative complications:
○ Centers for Disease Control criteria for Surgi-
cal Site Infection, according to the guidelines
proposed by Mangram in 1999 [36] Appendix 1.
○ Wound haematoma: accumulation of blood in
the wound area, which warrants surgical explora-
tion and intervention.
○ Pulmonary infections
○ Ventilation problems
○ Re-admission and indication
○ VAS pain score until day 6 post operative
At 1 and 12 months, ultrasound imaging will be per-
formed to examine the midline for any asymptomatic
clinically not detectable incisional hernias. Size and loca-
tion of any incisional hernias will be registered.
Outpatient clinic follow up
• Outpatient clinic visit at 1 and 12 months
○ Incisional hernia
○ Wound infection
○ Seroma formation
○ Other wound problems
○ Other abdominal wall hernia
• Ultrasound at 1 and 12 months
• VAS pain scores and Quality of Life forms preo-
peratively (day of operation or the day before) and at
1,3, 6 and 12 months
Ultrasound examinations
During the 1 month and 1 year follow up an ultra sound
examination will be performed to measure the distance
between the rectus muscles at 3 point in the incision and
check for incisional hernia. A specific score is used for the
ultrasound examination. At ten points, which include 4
measurements of the distance between the rectus muscle,
the quality of the scar in the abdominal wall is objectified.
With this method the conclusion if there is an incisional
hernia can also be made on the score list. In this list is
controlled for:
An intact linea alba?
Bulging without Valsalva manouvre?
Bulging with Valsalva manouvre?
Distance between rectus muscles in scar on 1/3 cranial
part in cm?
Distance between rectus muscles in scar on 1/3 caudal
part in cm?
Maximum distance between rectus muscles in scar in
cm?
Maximum distance between rectus muscles at place of
bulging or defect in cm?
Is there a defect? If yes, the size of the defect and
location
Is there fatty tissue in the defect?
Is there a bowel loop in the defect?
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The radiologist is asked to make prints of every mea-
surement and finding.
Quality of life will be assessed based on standardized
Quality of Life forms including the EuroQol-5D and Short
Form-36 before and at 1 month, 3 months, 6 months, and
12 months after surgery.
Economic evaluation
We will perform an ex-post economic evaluation in
which a new suture technique using small bites is com-
pared with the traditionally applied large bites technique,
from a societal perspective. The economic evaluation will
be performed in accordance with Dutch guidelines (Oos-
tenbrink, 2004).
To measure the economic impact of the new suture
technique using small bites the cost-effectiveness will be
assessed by calculating the incremental cost-effectiveness
ratio, defined here as the difference in average costs
between both suture techniques divided by the difference
in average effects. The primary outcome measure will be
the costs per reduced incisional hernia within 1 year. Sec-
ondary, a cost-utility analysis will be performed using
costs per quality adjusted life year (QALY) as outcome
measure, using the EQ-5D.
Costs for all separate actions and time used by all indivi-
dual health care professionals, and all other materials will
be measured from a societal perspective for both bites
techniques, which means that both direct medical costs
(e.g. intervention costs, intramural and extramural medical
costs) and indirect costs (absence from work, patient
costs) will be included in the analysis.
For the most important cost items, unit prices will be
determined by following the micro-costing method (Gold
et al, 1996), which is based on a detailed inventory and
measurement of all resources used. Resource costs arise
within the hospital and consist of outpatient visits, inpati-
ent days, use of the operation room, radiology examina-
tions, blood tests, etc. Real medical costs will be calculated
by multiplying the volumes of health care use with the
corresponding unit prices. For instance, the calculation of
the costs of both suture techniques will consist of detailed
measurement of investments in manpower, equipment,
materials, housing and overhead. The salary schemes of
hospitals and other health care suppliers will be used to
estimate costs per hour for each health care professional.
Taxes, social securities and vacations will be included.
Data on effects (reduction of incisional hernia), costs
(time costs of new suture technique and material and
development costs) and savings (reduced health care use
of patients without incisional hernia) will all be collected
in this study. Data on treatment (hospitalisation) and fol-
low-up consultations will be collected retrospectively from
(electronic) patient charts and hospital administration.
This data will be collected by health care professionals
using a data-collection form. Information will collected on:
- length of hospital stay
- length of stay in ICU
- reinterventions
Data on extramural care, work absence and other
patient costs will be gathered via questionnaires at each
follow-up (1 and 12 months).
For a description of the calculation of the effect mea-
sures see paragraph ‘outcome parameters’.
Discounting of future costs and effects is not relevant
because of the limited time horizon of 1 year. When costs
of a treatment are similar across subgroups, the absolute
benefit determines the cost-effectiveness of a treatment for
a specific subgroup.
Randomized controlled trials are designed to evaluate the
effects of treatment at the group level, and cost-effective-
ness is usually calculated for this group as a whole. There
could however be substantial and relevant between sub-
group variability. It is therefore common to consider sub-
group specific effects of interventions. The subgroup
specific cost-effectiveness will be estimated by first deriving
a prognostic index, based on the predefined predictors of
incisional hernia: abdominal aneurysm aorta (AAA), obe-
sity, diabetes, COPD, corticosteroid usage, radiotherapy,
cardiovascular disease, smoking, age, cancer, other abdom-
inal wall hernias and collagen disorders.
Sample size calculation
Millbourn et al. found a decrease in the incidence of inci-
sional hernia from 18% to 5,6% in a randomized controlled
trial [34]. In this trial, follow-up consisted of clinical
instead of radiological examination for incisional hernia
occurrence. In this trial, ultrasound examination will be
used in order to be able to diagnose incisional hernia with
higher sensitivity. It is expected that a relative decrease of
the incidence incisional hernia after one year of 50% is rea-
sonable. The mean reported one year incidence of inci-
sional hernia in literature is 15%[1-5]. In order to reduce
the mean incidence of incisional hernia from 15 to 7.5%,
power calculations showed that two groups of 259 evalu-
able patients each are needed (power = 0.80, alfa = 0.05).
Loss to follow-up is estimated at 10% of included patients.
A total of 576 patients (2 × 288) will be included in the
study to correct for loss to follow-up. Overall effects will
be calculated adjusted for predictive baseline characteris-
tics, which will lead to a higher statistical power.
Statistical analysis
Descriptive statistics will include median and interquar-
tile range for continuous variables, and absolute num-
bers (with %) for categorical variables. Randomized
groups will be compared for imbalance without formal
statistical testing. Analysis will be by intention-to-treat.
Differences between randomized groups will be tested
with appropriate statistical methods, including t-tests or
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Mann-Whitney tests for continuous variables (consider-
ing whether the normality assumption is rejected by the
Kolmogorov-Smirnov test with Lilliefors correction test),
and chi-square tests for categorical variables. The pri-
mary outcome (incisional hernia) will be analyzed with
Kaplan-Meier analysis and a Cox regression analysis, to
adjust for any loss to follow up between 30 days and 1
year after surgery. The primary analysis is a covariate
adjusted Cox model, which includes the following pre-
defined, well-establihed predictors of incisional hernia:
abdominal aneurysm aorta (AAA), obesity, diabetes, cor-
ticosteroid usage, radiotherapy, COPD, smoking, age,
cancer, inguinal hernia, cardiovascular disease and col-
lagen disorders.
Subgroup effects will be assessed by tests of interaction
to prevent overinterpretation of apparent differences in
effectiveness. Quality of life data will be analyzed by paired
T-tests, comparing baseline with follow-up measurements,
and repeated measures analysis. A two-sided p < 0.05 will
be taken to indicate statistical significance.
Monitoring
The Erasmus University Medical center is the sponsor of
this trial. Adverse events are defined as any undesirable
experience occurring to a subject during a clinical trial,
whether or not considered related to the investigational
intervention. All adverse events reported spontaneously
by the subject or observed by the investigator or his staff
will be recorded. A serious adverse event (SAE) is any
untoward medical occurrence or effect that at any dose
results in death; is life threatening (at the time of the
event); requires hospitalization or prolongation of exist-
ing inpatients’ hospitalization; results in persistent or sig-
nificant disability or incapacity; is a new event of the trial
likely to affect the safety of the subjects, such as an unex-
pected outcome of an adverse reaction, major safety find-
ing from a newly completed animal study, etc. All SAEs
will be reported to the accredited Medical Ethical Com-
mittee (MEC) that approved the protocol, according to
the requirements of that MEC. Serious Adverse events
are death and burst abdomen. Adverse Events are read-
mission and reoperations.
An independent data and safety monitoring committee
will evaluate the progress of the trial and will examine
safety parameters every 3 months. The committee can
unblind the data whenever deemed necessary based on
reported adverse events. All involved physicians will repe-
titively be asked to report any potential adverse events
caused by the study protocol. These adverse events will be
listed and discussed with the monitoring committee. The
monitoring committee can ask for a full report in order to
discuss a specific adverse event. A copy of this report will
be sent to the central ethics board and to the involved
physicians. All deceased patients will be evaluated by the
safety committee for cause of death and possible trial
related serious adverse effects. Every death will be reported
to the central ethics board and the local ethics board. The
Data Safety Monitoring Board will consist of an epidemiol-
ogist/statistician and two independent surgeons.
Ethics
This study will be conducted in accordance with the prin-
ciples of the Declaration of Helsinki and ‘good clinical
practice’ guidelines. The Medical Ethical Committee of the
Erasmus University Medical Center Rotterdam has
approved the protocol. The Ethical Committees of the par-
ticipating centers are applied for local feasibility. Prior to
randomization, written informed consent will be obtained
from all patients.
Discussion
A major issue in all suture studies is standardisation of
technique. In a multicenter trial it is difficult to achieve
standardisation because many surgeons and residents will
contribute in this trial. The benefit of a large group of par-
ticipants is that the results will be representable for daily
practice.
In this trial two major parameters have been standar-
dized: the difference between small and large bites and
the amount of stitches per running cm of wound result-
ing in an appropriate SL:WL ratio.
In daily practice, most surgeons use the large bite tech-
nique with large suture distances. With large bites, SL:WL
ratio depends on the thickness of the abdominal wall
including the muscles, the bite size, the number of stitches
and the traction on the sutures during suturing. With
large bites there is an unanswered question under which
conditions an optimal SL:WL ratio of 4 should be reach-
able. With low traction on the suture fewer stitches are
needed, but the slacking effect during the postoperative
period will influence the results. For this reason in a RCT
on suture techniques it is necessary to standardize the
amount of stitches per centimetre of wound length.
Conclusion
The STITCH trial is a multicenter randomized trial (trial-
register: http://clinicaltrials.gov/ct2/show/NCT01132209)
comparing the costs and effectiveness of a standardized
small tissue bites suture technique with a standardized
large tissue bites technique in midline incisions. This trial
will provide the surgical society the evidence needed to
optimize a surgical technique used to prevent common
surgical complications.
Appendix 1
Criteria for defining a Surgical Site Infection (SSI)
Superficial Incisional SSI
Infection occurs within 30 days after the operation and
infection involves only skin or subcutaneous tissue of
the incision and at least one of the following:
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1. Purulent drainage, with or without laboratory
confirmation, from the superficial incision.
2. Organisms isolated from an aseptically obtained
culture of fluid or tissue from the superficial
incision.
3. At least one of the following signs or symptoms of
infection: pain or tenderness, localized swelling, red-
ness or heat and superficial incision is deliberately
opened by surgeon, unless incision is culture-negative.
4. Diagnosis of superficial incisional SSI by the sur-
geon or attending physician.
Do not report the following conditions as SSI:
1. Stitch abscess (minimal inflammation and dis-
charge confined to the points of suture penetration).
2. Incisional SSI that extends into the fascial and
muscle layers (see deep incisional SSI).
Deep Incisional SSI
Infection occurs within 30 days after the operation if no
implant is left in place or within 1 year if implant is in
place and the infection appears to be related to the opera-
tion and
infection involves deep soft tissue (e.g., fascial and
muscle tissue) of the incision and at least one of the
following:
1. Purulent drainage from the deep incision but not
from the organ/space component of the surgical site.
2. A deep incision spontaneously dehisces or is
deliberately opened by a surgeon when the patient
has at least one of the following signs or symptoms:
fever (> 38°C), localized pain, or tenderness, unless
site is culture negative.
3. An abscess or other evidence of infection invol-
ving the deep incision is found on direct examina-
tion, during re-operation, or by histopathological or
radiological examination.
4. Diagnosis of a deep incisional SSI by a surgeon or
attending physician.
Notes
1. Report infection that involves both superficial and
deep incision sites as deep incisional SSI.
2. Report an organ/space SSI that drains through the
incision as a deep incisional SSI.
Organ/Space SSI
Infection occurs within 30 days after the operation if no
implant is left in place or within 1 year if implant is in
place and the infection appears to be related to the
operation and infection involves any part of the anatomy
(e.g., organs or spaces), other than the incision, which
was opened or manipulated during an operation and at
least one of the following:
1. Purulent drainage from drain that is placed
through a stab wound into the organ/space.
2. Organisms isolated from an aseptically obtained
culture of fluid or tissue in the organ space.
3. An abscess or other evidence of infection invol-
ving the organ/space that is found on direct exami-
nation, during reoperation, or by histopathologic or
radiologic examination.
4. Diagnosis of a deep organ/space SSI by a surgeon
or attending physician.
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